Man Shen
Overview
Explore the profile of Man Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Q, Shen M, Xu H, Wang J, Wang R, Xiao T, et al.
Adv Healthc Mater
. 2025 Jan;
:e2405038.
PMID: 39888282
Developing nanoscale platforms with high integration, assembly efficiency, and structural stability for performing complex computations in specific cells remains a significant challenge. To address this, the Three-dimensional Hierarchical Octahedral Robotic...
2.
Deng F, Shen M, Jia C, Han P, Liang X
Int J Biol Macromol
. 2024 Dec;
291:138986.
PMID: 39708878
The recombinated amylopullulanase of PulW310B, pullulanase from Bacillus aryabhattai W310, was characterized. Sequence analysis of PulW310B showed that PulW310B has type I pullulanase structures including its typical region and the...
3.
Shen M, Dai X, Ning D, Xu H, Zhou Y, Chen G, et al.
Front Immunol
. 2024 Aug;
15:1392259.
PMID: 39086491
The treatment of wound inflammation is intricately linked to the concentration of reactive oxygen species (ROS) in the wound microenvironment. Among these ROS, HO serves as a critical signaling molecule...
4.
Qiu X, Yang H, Shen M, Xu H, Wang Y, Liu S, et al.
J Nanobiotechnology
. 2024 May;
22(1):274.
PMID: 38773614
Small extracellular vesicle-derived microRNAs (sEV-miRNAs) have emerged as promising noninvasive biomarkers for early cancer diagnosis. Herein, we developed a molecular probe based on three-dimensional (3D) multiarmed DNA tetrahedral jumpers (mDNA-Js)-assisted...
5.
Xu H, Wu X, Liu Q, Yang C, Shen M, Wang Y, et al.
ACS Nano
. 2023 Dec;
18(1):436-450.
PMID: 38149638
Rolling circle amplification (RCA) is one of the most promising nucleic acid detection technologies and has been widely used in the molecular diagnosis of disease. Padlock probes are often used...
6.
Zhan X, Liu X, Rang L, Shen M, Zhang J, Tang R, et al.
Clin Chim Acta
. 2023 Dec;
553:117707.
PMID: 38103853
Lenalidomide is the first-line drug for the clinical treatment of multiple myeloma. However, its efficacy differs significantly among patients. Clinically, after lenalidomide treatment, few patients' conditions worsened, whereas others remained...
7.
Shi Y, Wu Y, Shen M, Yang J, Qin Y, Liu S, et al.
Integr Cancer Ther
. 2023 Apr;
22:15347354231164621.
PMID: 37029546
Doxorubicin (Dox) is a first-line chemotherapeutic agent applied in cancer treatment. Its long-term anticancer efficacy is restricted mainly due to its subsequent cardiotoxicity for patients. (PG), an important traditional Chinese...
8.
Hu W, Song J, Li X, Pei X, Zhang J, Shen M, et al.
World J Clin Cases
. 2022 Dec;
10(33):12365-12374.
PMID: 36483807
Background: Multiple myeloma (MM) complicated with extramedullary disease (EMD) has a poor prognosis and is a limiting factor in the treatment of MM, and no standard treatment is recommended in...
9.
Yang C, Yuan Y, Shen M, Wang K, Xu H, Wang Y, et al.
Anal Chem
. 2022 Nov;
94(45):15887-15895.
PMID: 36325814
tRNA-derived small RNA (tsRNA) has emerged as a new biomarker for early diagnosis and prognosis prediction of breast cancer. Like the detection of other small non-coding RNAs, the traditional DNA...
10.
Wei Y, Wang J, Chen F, Li X, Zhang J, Shen M, et al.
Front Oncol
. 2022 Mar;
12:808290.
PMID: 35296015
Aims: To evaluate abnormal metabolites related to treatment response and prognosis of multiple myeloma (MM) patients through ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS). Methods: Forty-six symptomatic MM patients...